Publications
- 4- years results of weekly trastuzumab and paklitaxel in the treatment with women with HER2/neu overexpressing advanced breast cancor: singl prospective study2004 | First Faculty of Medicine
- Efficacy of weekly transtuzumab and paclitaxel in the treatment of women with HER-2/neu overexpressing metastatic breast cancer. The impact of taxane free interval on treatment outcomes2002 | First Faculty of Medicine
- Weekly Administration of Trastuzumab (T) and Paclitaxel (P) in thePublication without faculty affiliation
- Weekly trastuzumab (T) and paclitaxel (P) in metastatic breast cancer (MBC). The impact of taxane free interval (TFI) on treatment outcomePublication without faculty affiliation
- New treatment options for HER2-dependent metastatic breast cancer2011 | First Faculty of Medicine
- Breast cancer2011 | First Faculty of Medicine
- Hepatocellular carcinoma2010 | First Faculty of Medicine
- Standards of medical practice and quality in health care - Malignant tumors of the ovary2009 | First Faculty of Medicine
- The integrated care for the younger age group of women with breast cancer2008 | First Faculty of Medicine
- Influence of chemotherapy to hormonal levels in postmenopausal breast cancer patients2008 | First Faculty of Medicine
Loading network view...